Serum 25 Hydroxy – D in Patients without Vitamin D Supplementation: Perspectives from Cohorts with Rheumatoid Arthritis and Systemic Lupus Erythematosus

Hypovitaminosis D is common in the sunny UAE. This study focusses on the perspectives of 25 hydroxy-D in patients with RA and others with SLE ((Autoimmune disease, ADs)) and to compare them to others of patients without ADs) .The latter were used as control group. All included individuals were without history of vitamin D intake. Hypovitaminosis D was common in the 3 groups (RA, SLE and controls). However, the prevalence of hypovitaminosis D in patients with each of ADs was significantly lower to that of the control group yet with higher means of 25 (OH) D levels. These findings were in contrast to those of number of regional and international studies conducted earlier. Data on the high prevalence of hypovitaminosis D and the low mean values of 25 (OH) D were comparable between the two groups of ADs. Overall, the results of this study may lead to some controversy or perhaps a challenge to the widespread understanding of the contrary as per previous international and regional studies. They also argue further the concept of specific association of hypovitaminosis D and autoimmune disease and certainly encourage wider estimation of 25(OH) D among larger numbers of patients in general medical practice. Finally, the outcomes of this work deserve further study/ies in larger groups in the future.